Tilray Brands Amends Credit Agreement

Ticker: TLRY · Form: 8-K · Filed: 2024-11-06T00:00:00.000Z

Sentiment: neutral

Topics: debt, financing

TL;DR

Tilray just tweaked its credit agreement, filing an 8-K on Nov 6th.

AI Summary

On October 31, 2024, Tilray Brands, Inc. filed an 8-K report detailing an amendment to its credit agreement. The amendment, effective November 6, 2024, modifies the terms of the company's existing credit facility, though specific financial impacts are not detailed in this filing.

Why It Matters

This filing indicates a change in Tilray's financing structure, which could impact its operational flexibility and future borrowing capacity.

Risk Assessment

Risk Level: low — The filing is a routine amendment to a credit agreement and does not appear to involve significant new risks or negative financial events.

Key Players & Entities

FAQ

What specific changes were made to the credit agreement?

The filing states that the credit agreement was amended, but the specific details of the changes are not provided in this summary 8-K.

What is the effective date of the amendment?

The amendment to the credit agreement is effective as of November 6, 2024.

What is the date of the earliest event reported in this 8-K?

The earliest event reported in this 8-K is dated October 31, 2024.

What is Tilray Brands, Inc.'s principal executive office address?

Tilray Brands, Inc.'s principal executive offices are located at 265 Talbot Street West, Leamington, Ontario, Canada, N8H 4H3.

What is the company's IRS Employer Identification Number?

The company's IRS Employer Identification Number is 82-4310622.

From the Filing

0001140361-24-045431.txt : 20241106 0001140361-24-045431.hdr.sgml : 20241106 20241106170218 ACCESSION NUMBER: 0001140361-24-045431 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20241031 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241106 DATE AS OF CHANGE: 20241106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray Brands, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824310622 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 241432032 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: Tilray, Inc. DATE OF NAME CHANGE: 20180213 8-K 1 ef20038185_8k.htm 8-K false 0001731348 0001731348 2024-10-31 2024-10-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2024 ( October 31, 2024 ) Tilray Brands, Inc. (Exact name of registrant as specified in its charter) Delaware   001-38594   82-4310622 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 265 Talbot Street West , Leamington , Ontario , Canada , N8H 4H3 (Address of principal executive offices, including zip code) Registrant’s telephone number, including area code: ( 844 ) 845-7291 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.0001 per share   TLRY   The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Sec. 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Sec. 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01. Other Events On October 31, 2024, Nabil Salama, on behalf of a putative class of stockholders of Tilray Brands, Inc., a Delaware corporation (“Tilray”), as a nominal defendant, filed a Verified Stockholder Class Action Complaint in the Court of Chancery of the State of Delaware (the “Court”), naming Tilray and each member of the Board of Directors of Tilray, as defendants (the “Action”). The complaint alleges that (a) the definitive proxy statement filed by Tilray for its 2024 Annual Meeting of Stockholders (the “2024 Proxy Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) on September 27, 2024 specifies that a majority-of-votes-cast voting stan

View on Read The Filing